Although reports from Japan and China document anti-MDA5 (anti-CADM140) dermatomyositis to have the most elevated serum neopterin level, especially in patients with severe lung disease [26,27], there was not a statistically significant difference in neopterin level between the different MSAs in our cohort. This evidence concerns the gene IFIH1 and lung disorder.